Published in Biochemistry on August 05, 2003
Assessing the lipid requirements of the Torpedo californica nicotinic acetylcholine receptor. Biochemistry (2006) 1.19
Anionic lipids allosterically modulate multiple nicotinic acetylcholine receptor conformational equilibria. J Biol Chem (2009) 1.05
Cholesterol interacts with transmembrane alpha-helices M1, M3, and M4 of the Torpedo nicotinic acetylcholine receptor: photolabeling studies using [3H]Azicholesterol. Biochemistry (2006) 1.04
Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicotinic acetylcholine receptor. Sci Rep (2011) 1.00
Electron spin resonance in membrane research: protein-lipid interactions from challenging beginnings to state of the art. Eur Biophys J (2009) 0.98
Stoichiometry of lipid interactions with transmembrane proteins--Deduced from the 3D structures. Protein Sci (2006) 0.87
Modulating inhibitory ligand-gated ion channels. AAPS J (2006) 0.86
Cations mediate interactions between the nicotinic acetylcholine receptor and anionic lipids. Biophys J (2010) 0.81
Interaction of spin-labeled inhibitors of the vacuolar H+-ATPase with the transmembrane Vo-sector. Biophys J (2007) 0.80
Fatty Acid Regulation of Voltage- and Ligand-Gated Ion Channel Function. Front Physiol (2016) 0.77
Partition profile of the nicotinic acetylcholine receptor in lipid domains upon reconstitution. J Lipid Res (2010) 0.77
Muscle-Type Nicotinic Receptor Modulation by 2,6-Dimethylaniline, a Molecule Resembling the Hydrophobic Moiety of Lidocaine. Front Mol Neurosci (2016) 0.75
Interaction of benzylidene-anabaseine analogues with agonist and allosteric sites on muscle nicotinic acetylcholine receptors. Br J Pharmacol (2009) 0.75
Uncovering the lipidic basis for the preparation of functional nicotinic acetylcholine receptor detergent complexes for structural studies. Sci Rep (2016) 0.75
Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am (2002) 5.95
Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse? N Engl J Med (2000) 4.67
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas (2009) 2.74
Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet (1995) 2.66
Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat Genet (1995) 2.64
CD95 signaling via ceramide-rich membrane rafts. J Biol Chem (2001) 2.48
X-ray diffraction study of the polymorphism of hydrated diacyl- and dialkylphosphatidylethanolamines. Biochemistry (1984) 2.45
Different membrane anchoring positions of tryptophan and lysine in synthetic transmembrane alpha-helical peptides. J Biol Chem (1999) 2.44
Calorimetric studies of the gel-fluid (L beta-L alpha) and lamellar-inverted hexagonal (L alpha-HII) phase transitions in dialkyl- and diacylphosphatidylethanolamines. Biochemistry (1983) 2.33
Partial enzyme deficiencies: residual activities and the development of neurological disorders. Dev Neurosci (1984) 2.23
Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis. Ann Intern Med (1980) 2.16
Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet (1992) 2.12
Enzyme alterations and lipid storage in three variants of Tay-Sachs disease. J Neurochem (1971) 2.11
Influence of lipid/peptide hydrophobic mismatch on the thickness of diacylphosphatidylcholine bilayers. A 2H NMR and ESR study using designed transmembrane alpha-helical peptides and gramicidin A. Biochemistry (1998) 2.07
A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci U S A (1999) 2.05
The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression. Genomics (1999) 2.04
AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2. Proc Natl Acad Sci U S A (1978) 2.02
A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest (1999) 1.96
Deficient hexozaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs. Life Sci (1968) 1.95
Titration of the phase transition of phosphatidylserine bilayer membranes. Effects of pH, surface electrostatics, ion binding, and head-group hydration. Biochemistry (1981) 1.90
Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs. J Biol Chem (1991) 1.89
Molecular motion in phospholipid bilayers in the gel phase: long axis rotation. Biochemistry (1980) 1.86
Determination of fluid and gel domain sizes in two-component, two-phase lipid bilayers. An electron spin resonance spin label study. Biophys J (1992) 1.85
Rhodopsin-lipid associations in bovine rod outer segment membranes. Identification of immobilized lipid by spin-labels. Biochemistry (1979) 1.81
Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta (2000) 1.77
Protein surface-distribution and protein-protein interactions in the binding of peripheral proteins to charged lipid membranes. Biophys J (1995) 1.77
Diameter of the cell-to-cell junctional membrane channels as probed with neutral molecules. Science (1981) 1.76
Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase, and sphinganine N-acyltransferase in mouse liver. J Biol Chem (1992) 1.76
Pheromone-regulated anemotaxis in flying moths. Science (1974) 1.71
Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Hum Mol Genet (1996) 1.70
STED nanoscopy reveals molecular details of cholesterol- and cytoskeleton-modulated lipid interactions in living cells. Biophys J (2011) 1.69
Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A. J Biol Chem (1985) 1.66
Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem (2000) 1.64
Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nat Genet (1996) 1.63
Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle. Osteoporos Int (2013) 1.60
Ganglioside metabolism. Enzymology, Topology, and regulation. J Biol Chem (1993) 1.59
Predicting survival after treatment for fracture of the proximal femur and the effect of delays to surgery. J Clin Epidemiol (2003) 1.57
Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts. EMBO J (1989) 1.55
Electron spin resonance: spin labels. Mol Biol Biochem Biophys (1981) 1.53
Structure, dynamics and composition of the lipid-protein interface. Perspectives from spin-labelling. Biochim Biophys Acta (1998) 1.52
Hydration of noncharged lipid bilayer membranes. Theory and experiments with phosphatidylethanolamines. Biophys J (1985) 1.51
Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice. J Clin Invest (1998) 1.49
Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification Of the first molecular lesion causing Farber disease. J Biol Chem (1996) 1.49
Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase A precursor towards ganglioside GM2. Eur J Biochem (1982) 1.48
Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell (1997) 1.47
Activator proteins and topology of lysosomal sphingolipid catabolism. Biochim Biophys Acta (1992) 1.46
The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts. Biol Chem Hoppe Seyler (1994) 1.46
[Enrichment and characterization of 2 forms of human N-acetyl-beta-D-hexosaminidase]. Hoppe Seylers Z Physiol Chem (1971) 1.45
Interaction of cholesterol with sphingomyelin in mixed membranes containing phosphatidylcholine, studied by spin-label ESR and IR spectroscopies. A possible stabilization of gel-phase sphingolipid domains by cholesterol. Biochemistry (2001) 1.43
GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients. Am J Hum Genet (1990) 1.43
Metastability and polymorphism in the gel and fluid bilayer phases of dilauroylphosphatidylethanolamine. Two crystalline forms in excess water. J Biol Chem (1983) 1.43
Lipid membrane expansion and micelle formation by polymer-grafted lipids: scaling with polymer length studied by spin-label electron spin resonance. Biophys J (2001) 1.40
Immobilized lipid in acetylcholine receptor-rich membranes from Torpedo marmorata. Proc Natl Acad Sci U S A (1978) 1.40
[Clinical aspects and therapy of amniotic fluid embolism. Illustration based on a case report]. Z Geburtshilfe Neonatol (1997) 1.39
Interactions of hydrophobic lung surfactant proteins SP-B and SP-C with dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylglycerol bilayers studied by electron spin resonance spectroscopy. Biochemistry (1995) 1.38
Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide. J Biol Chem (1997) 1.37
An interacting spin label study of the fluidizing and condensing effects of cholesterol on lecithin bilayers. Biochim Biophys Acta (1973) 1.36
Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level. Am J Hum Genet (1983) 1.36
Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study. J Inherit Metab Dis (2005) 1.36
Metabolism and intracellular transport of glycosphingolipids. Biochemistry (1990) 1.34
Control of the structure and fluidity of phosphatidylglycerol bilayers by pH titration. Biochim Biophys Acta (1978) 1.34
Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas (2013) 1.34
Peptide extraction by alkaline treatment is accompanied by rearrangement of the membrane-bound acetylcholine receptor from Torpedo marmorata. FEBS Lett (1980) 1.34
Evidence for phase boundary lipid. Permeability of Tempo-choline into dimyristoylphosphatidylcholine vesicles at the phase transition. Biochemistry (1976) 1.34
Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs. Pathol Eur (1968) 1.34
The nicotinic cholinergic receptor : different compositions evidenced by statistical analysis. Biochem Biophys Res Commun (1975) 1.33
Sphingolipid activator proteins are required for epidermal permeability barrier formation. J Biol Chem (1999) 1.32
Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins. Biol Chem (2001) 1.32
Agonist-activated ionic channels in acetylcholine receptor reconstituted into planar lipid bilayers. Proc Natl Acad Sci U S A (1981) 1.32
Spin-label studies of lipid immobilization in dimyristoylphosphatidylcholine-substituted cytochrome oxidase. Biochemistry (1979) 1.32
Investigation of secondary and tertiary structural changes of cytochrome c in complexes with anionic lipids using amide hydrogen exchange measurements: an FTIR study. Biophys J (1993) 1.29
Cerebroside sulfatase activator deficiency induced metachromatic leukodystrophy. Am J Hum Genet (1981) 1.29
Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons. J Biol Chem (1999) 1.29
Nanoscale organization of nicotinic acetylcholine receptors revealed by stimulated emission depletion microscopy. Neuroscience (2006) 1.28
Electron spin resonance study of phospholipid membranes employing a comprehensive line-shape model. Biochemistry (1985) 1.28
A simple and novel method for tritium labeling of gangliosides and other sphingolipids. Biochim Biophys Acta (1978) 1.27
Acid sphingomyelinase from human urine: purification and characterization. Biochim Biophys Acta (1987) 1.26
Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease. J Inherit Metab Dis (2004) 1.26
Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease. FEBS Lett (1991) 1.26
Cellular uptake of saposin (SAP) precursor and lysosomal delivery by the low density lipoprotein receptor-related protein (LRP). EMBO J (1998) 1.25
Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J Biol Chem (1993) 1.25
A mutation in the gene of a glycolipid-binding protein (GM2 activator) that causes GM2-gangliosidosis variant AB. FEBS Lett (1991) 1.24
Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A. Hoppe Seylers Z Physiol Chem (1979) 1.24
Lysogangliosides: synthesis and use in preparing labeled gangliosides. Methods Enzymol (1987) 1.24
Binding of peripheral proteins to mixed lipid membranes: effect of lipid demixing upon binding. Biophys J (1999) 1.24
Purification, characterization, and biosynthesis of human acid ceramidase. J Biol Chem (1995) 1.23
Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure. Proc Natl Acad Sci U S A (1998) 1.23
Modulation of chloroplast membrane lipids by homogeneous catalytic hydrogenation. Eur J Biochem (1985) 1.22
Pneumonia perceptions and management: an ethnographic study in urban squatter settlements of Karachi, Pakistan. Soc Sci Med (1997) 1.22
ESR spin-label studies of lipid-protein interactions in membranes. Biophys J (1982) 1.20
Binary phase diagram of hydrated dimyristoylglycerol-dimyristoylphosphatidylcholine mixtures. Biophys J (1992) 1.20
Specificity of human liver hexosaminidases A and B against glycosphingolipids GM2 and GA2. Purification of the enzymes by affinity chromatography employing specific elution. Hoppe Seylers Z Physiol Chem (1977) 1.20
Biochemistry and genetics of gangliosidoses. Hum Genet (1979) 1.20
Cytochrome c-lipid interactions studied by resonance Raman and 31P NMR spectroscopy. Correlation between the conformational changes of the protein and the lipid bilayer. Biochemistry (1991) 1.20
Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators. J Biol Chem (1998) 1.20